Highlights
KLSE: YSPSAH (7178)       Y.S.P. SOUTHEAST ASIA HOLDING BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
2.43   -0.02 (0.82%)  2.38 - 2.46  108,400
Trade this stock for as low as 0.05% brokerage. Find out more.

Financials


Market Cap: 342 Million

Market Cap 342 Million
NOSH 141 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 29-May-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 29-May-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Jun-2020 [#2]

Latest Quarter: 30-Jun-2020 [#2]
Announcement Date 25-Aug-2020
Next Quarter: 30-Sep-2020
Est. Ann. Date: 19-Nov-2020
Est. Ann. Due Date: 29-Nov-2020
QoQ | YoY   104.74%  |    84.90%

Annual (Unaudited) ( EPS: 16.35, P/E: 14.86 )

Revenue | NP to SH 295,619  |  23,012
RPS | P/RPS 210.02 Cent  |  1.16
EPS | P/E | EY 16.35 Cent  |  14.86  |  6.73%
DPS | DY | Payout % 8.43 Cent  |  3.47%  |  51.56%
NAPS | P/NAPS 2.33  |  1.04
YoY   -24.18%
NP Margin | ROE 7.60%  |  7.02%
F.Y. | Ann. Date 31-Dec-2019  |  25-Feb-2020

T4Q Result ( EPS: 20.83, P/E: 11.67 )

Revenue | NP to SH 299,549  |  29,316
RPS | P/RPS 212.82 Cent  |  1.14
EPS | P/E | EY 20.83 Cent  |  11.67  |  8.57%
DPS | DY | Payout % 7.94 Cent  |  3.27%  |  38.13%
NAPS | P/NAPS 2.37  |  1.02
QoQ | YoY   22.56%  |    19.86%
NP Margin | ROE 9.62%  |  8.78%
F.Y. | Ann. Date 30-Jun-2020  |  25-Aug-2020

Annualized Result ( EPS: 24.86, P/E: 9.78 )

Revenue | NP to SH 296,530  |  34,990
RPS | P/RPS 210.67 Cent  |  1.15
EPS | P/E | EY 24.86 Cent  |  9.78  |  10.23%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   52.37%  |    56.33%
NP Margin | ROE 11.73%  |  10.48%
F.Y. | Ann. Date 30-Jun-2020  |  25-Aug-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2020 25-Aug-2020 30-Jun-2020 2 67,728 13,729 11,857 11,754 11,179 333,981 95.11% 17.51% 3.52% 139,741 48.47 48.12 8.41 8.35 8.00 7.94 2.3900 2.37   104.74%   84.90% 30-Jun-2020 2.31 4.77 27.46 0.97 3.64% 3.46% 25-Aug-2020 2.54 5.24 30.20 1.06 3.31% 3.15%
31-Dec-2020 21-May-2020 31-Mar-2020 1 80,537 9,041 5,528 5,741 - 335,080 - % 6.86% 1.71% 139,617 57.68 57.22 4.11 4.08 0.00 0.00 2.4000 2.38   51.60%   18.76% 31-Mar-2020 1.82 3.16 44.26 0.76 2.26% 0.00% 21-May-2020 2.26 3.92 54.96 0.94 1.82% 0.00%
31-Dec-2019 25-Feb-2020 31-Dec-2019 4 77,116 6,758 3,625 3,787 - 328,027 - % 4.70% 1.15% 139,586 55.25 54.79 2.71 2.69 0.00 0.00 2.3500 2.33   -52.86%   -44.66% 31-Dec-2019 2.33 4.22 85.88 0.99 1.16% 0.00% 25-Feb-2020 2.21 4.00 81.46 0.94 1.23% 0.00%
31-Dec-2019 19-Nov-2019 30-Sep-2019 3 74,168 9,837 7,814 8,034 - 326,624 - % 10.54% 2.46% 139,583 53.14 52.69 5.76 5.71 0.00 0.00 2.3400 2.32   26.38%   25.06% 30-Sep-2019 2.32 4.37 40.31 0.99 2.48% 0.00% 19-Nov-2019 2.33 4.39 40.48 1.00 2.47% 0.00%
31-Dec-2019 29-Aug-2019 30-Jun-2019 2 69,597 8,238 6,223 6,357 11,811 314,056 185.81% 8.94% 2.02% 138,963 50.08 49.45 4.57 4.52 8.50 8.39 2.2600 2.23   31.51%   -38.60% 28-Jun-2019 2.46 4.91 53.78 1.09 1.86% 3.46% 29-Aug-2019 2.30 4.59 50.28 1.02 1.99% 3.70%
31-Dec-2019 28-May-2019 31-Mar-2019 1 74,738 6,999 4,816 4,834 - 318,156 - % 6.44% 1.52% 138,329 54.03 53.10 3.49 3.43 0.00 0.00 2.3000 2.26   -29.36%   -28.16% 29-Mar-2019 2.85 5.27 81.56 1.24 1.23% 0.00% 28-May-2019 2.49 4.61 71.25 1.08 1.40% 0.00%
31-Dec-2018 26-Feb-2019 31-Dec-2018 4 76,041 9,386 6,689 6,843 - 315,262 - % 8.80% 2.17% 138,273 54.99 54.02 4.95 4.86 0.00 0.00 2.2800 2.24   6.52%   33.63% 31-Dec-2018 2.75 5.00 55.57 1.21 1.80% 0.00% 26-Feb-2019 2.88 5.24 58.19 1.26 1.72% 0.00%
31-Dec-2018 21-Nov-2018 30-Sep-2018 3 73,275 9,177 6,422 6,424 - 306,437 - % 8.76% 2.10% 138,035 53.08 52.06 4.65 4.56 0.00 0.00 2.2200 2.18   -37.96%   92.97% 28-Sep-2018 3.25 6.12 69.83 1.46 1.43% 0.00% 21-Nov-2018 3.01 5.67 64.68 1.36 1.55% 0.00%
31-Dec-2018 13-Aug-2018 30-Jun-2018 2 67,850 13,651 10,419 10,354 9,620 298,236 92.92% 15.36% 3.47% 137,436 49.37 48.20 7.53 7.36 7.00 6.83 2.1700 2.12   53.87%   227.14% 29-Jun-2018 2.55 5.17 33.85 1.18 2.95% 2.75% 13-Aug-2018 2.80 5.67 37.17 1.29 2.69% 2.50%
31-Dec-2018 25-May-2018 31-Mar-2018 1 71,593 10,090 6,603 6,729 - 297,511 - % 9.22% 2.26% 137,102 52.22 50.86 4.91 4.78 0.00 0.00 2.1700 2.11   31.40%   -23.25% 30-Mar-2018 2.50 4.79 50.94 1.15 1.96% 0.00% 25-May-2018 2.50 4.79 50.94 1.15 1.96% 0.00%
31-Dec-2017 28-Feb-2018 31-Dec-2017 4 68,017 8,067 5,085 5,121 - 289,871 - % 7.48% 1.77% 136,732 49.74 48.32 3.75 3.64 0.00 0.00 2.1200 2.06   53.83%   -57.15% 29-Dec-2017 2.69 5.41 71.82 1.27 1.39% 0.00% 28-Feb-2018 2.52 5.07 67.28 1.19 1.49% 0.00%
31-Dec-2017 16-Nov-2017 30-Sep-2017 3 66,093 5,384 3,299 3,329 - 282,419 - % 4.99% 1.18% 136,434 48.44 46.96 2.44 2.37 0.00 0.00 2.0700 2.01   5.18%   -15.51% 29-Sep-2017 2.99 6.17 122.54 1.44 0.82% 0.00% 16-Nov-2017 2.86 5.90 117.21 1.38 0.85% 0.00%
31-Dec-2017 29-Aug-2017 30-Jun-2017 2 59,907 4,563 3,036 3,165 11,496 275,923 363.25% 5.07% 1.15% 135,256 44.29 42.56 2.34 2.25 8.50 8.17 2.0400 1.96   -63.90%   -53.58% 30-Jun-2017 2.92 6.59 124.79 1.43 0.80% 2.91% 29-Aug-2017 2.87 6.48 122.65 1.41 0.82% 2.96%
31-Dec-2017 23-May-2017 31-Mar-2017 1 67,539 11,674 8,644 8,767 - 282,806 - % 12.80% 3.10% 134,669 50.15 47.98 6.51 6.23 0.00 0.00 2.1000 2.01   -26.64%   79.43% 31-Mar-2017 2.32 4.63 35.64 1.10 2.81% 0.00% 23-May-2017 2.30 4.59 35.33 1.10 2.83% 0.00%
31-Dec-2016 22-Feb-2017 31-Dec-2016 4 59,719 13,991 11,896 11,950 - 274,836 - % 19.92% 4.35% 134,723 44.33 42.43 8.87 8.49 0.00 0.00 2.0400 1.95   203.30%   87.83% 30-Dec-2016 1.91 4.31 21.53 0.94 4.64% 0.00% 22-Feb-2017 2.09 4.71 23.56 1.02 4.24% 0.00%
31-Dec-2016 15-Nov-2016 30-Sep-2016 3 59,194 6,060 4,043 3,940 - 264,907 - % 6.83% 1.49% 134,470 44.02 42.05 2.93 2.80 0.00 0.00 1.9700 1.88   -42.21%   -59.95% 30-Sep-2016 2.24 5.09 76.45 1.14 1.31% 0.00% 15-Nov-2016 2.10 4.77 71.67 1.07 1.40% 0.00%
31-Dec-2016 15-Aug-2016 30-Jun-2016 2 51,848 8,657 7,020 6,818 10,779 260,054 158.10% 13.54% 2.62% 134,743 38.48 36.84 5.06 4.84 8.00 7.66 1.9300 1.85   39.54%   99.24% 30-Jun-2016 2.21 5.74 43.68 1.15 2.29% 3.62% 15-Aug-2016 2.14 5.56 42.29 1.11 2.36% 3.74%
31-Dec-2016 27-May-2016 31-Mar-2016 1 66,304 7,609 4,959 4,886 - 263,817 - % 7.48% 1.85% 134,600 49.26 47.11 3.63 3.47 0.00 0.00 1.9600 1.87   -23.20%   -47.72% 31-Mar-2016 2.40 4.87 66.12 1.22 1.51% 0.00% 27-May-2016 2.31 4.69 63.64 1.18 1.57% 0.00%
31-Dec-2015 26-Feb-2016 31-Dec-2015 4 53,665 7,395 6,594 6,362 - 258,246 - % 12.29% 2.46% 134,503 39.90 38.13 4.73 4.52 0.00 0.00 1.9200 1.83   -35.33%   -9.35% 31-Dec-2015 2.48 6.22 52.43 1.29 1.91% 0.00% 26-Feb-2016 2.61 6.54 55.18 1.36 1.81% 0.00%
31-Dec-2015 24-Nov-2015 30-Sep-2015 3 59,319 13,493 9,908 9,838 - 252,669 - % 16.70% 3.89% 134,398 44.14 42.14 7.32 6.99 0.00 0.00 1.8800 1.80   187.49%   222.03% 30-Sep-2015 2.32 5.26 31.69 1.23 3.16% 0.00% 24-Nov-2015 2.48 5.62 33.88 1.32 2.95% 0.00%
31-Dec-2015 18-Aug-2015 30-Jun-2015 2 50,632 5,393 3,474 3,422 8,654 239,673 252.92% 6.86% 1.43% 133,151 38.03 35.97 2.57 2.43 6.50 6.15 1.8000 1.70   -63.39%   254.98% 30-Jun-2015 2.62 6.89 101.95 1.46 0.98% 2.48% 18-Aug-2015 2.33 6.13 90.66 1.29 1.10% 2.79%
31-Dec-2015 14-May-2015 31-Mar-2015 1 59,309 13,246 9,397 9,346 - 244,966 - % 15.84% 3.82% 133,133 44.55 42.14 7.02 6.64 0.00 0.00 1.8400 1.74   33.17%   71.33% 31-Mar-2015 1.60 3.59 22.79 0.87 4.39% 0.00% 14-May-2015 1.61 3.61 22.93 0.88 4.36% 0.00%
31-Dec-2014 27-Feb-2015 31-Dec-2014 4 54,861 9,977 7,194 7,018 - 235,708 - % 13.11% 2.98% 133,168 41.20 38.98 5.27 4.99 0.00 0.00 1.7700 1.67   129.72%   72.35% 31-Dec-2014 1.30 3.16 24.67 0.73 4.05% 0.00% 27-Feb-2015 1.50 3.64 28.46 0.85 3.51% 0.00%
31-Dec-2014 27-Nov-2014 30-Sep-2014 3 49,821 5,003 3,167 3,055 - 227,132 - % 6.36% 1.35% 132,826 37.51 35.40 2.30 2.17 0.00 0.00 1.7100 1.61   216.91%   -26.69% 30-Sep-2014 1.55 4.13 67.39 0.91 1.48% 0.00% 27-Nov-2014 1.42 3.79 61.74 0.83 1.62% 0.00%
31-Dec-2014 29-Aug-2014 30-Jun-2014 2 46,112 2,267 1,118 964 8,702 224,933 902.78% 2.42% 0.43% 133,888 34.44 32.76 0.72 0.68 6.50 6.18 1.6800 1.60   -82.33%   -72.57% 30-Jun-2014 1.70 4.94 236.11 1.01 0.42% 3.82% 29-Aug-2014 1.68 4.88 233.33 1.00 0.43% 3.87%
31-Dec-2014 20-May-2014 31-Mar-2014 1 51,432 7,983 5,612 5,455 - 231,504 - % 10.91% 2.36% 133,048 38.66 36.54 4.10 3.88 0.00 0.00 1.7400 1.64   33.96%   22.92% 31-Mar-2014 1.41 3.65 34.39 0.81 2.91% 0.00% 20-May-2014 1.70 4.40 41.46 0.98 2.41% 0.00%
31-Dec-2013 26-Feb-2014 31-Dec-2013 4 48,784 5,540 4,167 4,072 - 226,222 - % 8.54% 1.80% 133,071 36.66 34.66 3.06 2.89 0.00 0.00 1.7000 1.61   -2.28%   56.62% 31-Dec-2013 1.34 3.66 43.79 0.79 2.28% 0.00% 26-Feb-2014 1.36 3.71 44.44 0.80 2.25% 0.00%
31-Dec-2013 12-Nov-2013 30-Sep-2013 3 46,638 5,363 4,327 4,167 - 222,328 - % 9.28% 1.87% 133,130 35.03 33.13 3.13 2.96 0.00 0.00 1.6700 1.58   18.58%   60.02% 30-Sep-2013 1.26 3.60 40.26 0.75 2.48% 0.00% 12-Nov-2013 1.30 3.71 41.53 0.78 2.41% 0.00%
31-Dec-2013 20-Aug-2013 30-Jun-2013 2 46,622 5,019 3,590 3,514 - 218,293 - % 7.70% 1.61% 133,106 35.03 33.12 2.64 2.50 0.00 0.00 1.6400 1.55   -20.82%   -22.63% 28-Jun-2013 1.29 3.68 48.86 0.79 2.05% 0.00% 20-Aug-2013 1.38 3.94 52.27 0.84 1.91% 0.00%
31-Dec-2013 16-May-2013 31-Mar-2013 1 48,783 6,097 4,564 4,438 - 223,228 - % 9.36% 1.99% 132,874 36.71 34.66 3.34 3.15 0.00 0.00 1.6800 1.59   70.69%   14.32% 29-Mar-2013 1.02 2.78 30.54 0.61 3.27% 0.00% 16-May-2013 1.10 3.00 32.93 0.65 3.04% 0.00%
31-Dec-2012 27-Feb-2013 31-Dec-2012 4 46,476 3,891 2,533 2,600 - 218,666 - % 5.45% 1.19% 133,333 34.86 33.02 1.95 1.85 0.00 0.00 1.6400 1.55   -0.15%   -38.90% 31-Dec-2012 1.04 2.98 53.33 0.63 1.88% 0.00% 27-Feb-2013 1.04 2.98 53.33 0.63 1.88% 0.00%
31-Dec-2012 14-Nov-2012 30-Sep-2012 3 45,551 4,696 2,651 2,604 - 215,228 - % 5.82% 1.21% 132,857 34.29 32.36 1.96 1.85 0.00 0.00 1.6200 1.53   -42.67%   -47.63% 28-Sep-2012 1.06 3.09 54.08 0.65 1.85% 0.00% 14-Nov-2012 1.08 3.15 55.10 0.67 1.81% 0.00%
31-Dec-2012 15-Aug-2012 30-Jun-2012 2 45,307 5,911 4,547 4,542 - 214,446 - % 10.04% 2.12% 133,196 34.02 32.19 3.41 3.23 0.00 0.00 1.6100 1.52   17.00%   76.73% 29-Jun-2012 1.09 3.20 31.96 0.68 3.13% 0.00% 15-Aug-2012 1.03 3.03 30.21 0.64 3.31% 0.00%
31-Dec-2012 25-May-2012 31-Mar-2012 1 43,276 5,653 3,840 3,882 - 216,700 - % 8.87% 1.79% 132,945 32.55 30.75 2.92 2.76 0.00 0.00 1.6300 1.54   -8.77%   8.34% 30-Mar-2012 1.02 3.13 34.93 0.63 2.86% 0.00% 25-May-2012 1.02 3.13 34.93 0.63 2.86% 0.00%
31-Dec-2011 27-Feb-2012 31-Dec-2011 4 42,236 5,228 4,348 4,255 - 212,749 - % 10.29% 2.00% 132,968 31.76 30.01 3.20 3.02 0.00 0.00 1.6000 1.51   -14.42%   12.33% 30-Dec-2011 1.00 3.15 31.25 0.63 3.20% 0.00% 27-Feb-2012 1.03 3.24 32.19 0.64 3.11% 0.00%
31-Dec-2011 30-Nov-2011 30-Sep-2011 3 39,573 5,925 5,011 4,972 - 188,097 - % 12.66% 2.64% 119,807 33.03 28.11 4.15 3.53 0.00 0.00 1.5700 1.34   93.46%   70.98% 30-Sep-2011 0.94 2.85 22.65 0.60 4.41% 0.00% 30-Nov-2011 0.95 2.88 22.89 0.61 4.37% 0.00%
31-Dec-2011 22-Aug-2011 30-Jun-2011 2 38,324 2,909 2,658 2,570 - 169,026 - % 6.94% 1.52% 98,846 38.77 27.23 2.60 1.83 0.00 0.00 1.7100 1.20   -28.27%   -12.70% 30-Jun-2011 1.11 2.86 42.69 0.65 2.34% 0.00% 22-Aug-2011 0.97 2.50 37.31 0.57 2.68% 0.00%
31-Dec-2011 25-May-2011 31-Mar-2011 1 36,640 4,604 3,710 3,583 - 172,734 - % 10.13% 2.07% 98,705 37.12 26.03 3.63 2.55 0.00 0.00 1.7500 1.23   -5.41%   42.35% 31-Mar-2011 1.07 2.88 29.48 0.61 3.39% 0.00% 25-May-2011 1.11 2.99 30.58 0.63 3.27% 0.00%
31-Dec-2010 25-Feb-2011 31-Dec-2010 4 38,941 5,308 3,927 3,788 5,913 98,553 156.10% 10.08% 3.84% 98,553 39.51 27.67 3.76 2.69 6.00 4.20 1.0000 0.70   30.26%   41.87% 30-Dec-2010 1.09 2.76 28.36 1.09 3.53% 5.50% 25-Feb-2011 1.10 2.78 28.62 1.10 3.49% 5.45%
31-Dec-2010 22-Nov-2010 30-Sep-2010 3 36,139 4,026 2,950 2,908 - 154,764 - % 8.16% 1.88% 98,576 36.66 25.68 2.95 2.07 0.00 0.00 1.5700 1.10   -1.22%   -14.09% 30-Sep-2010 1.12 3.06 37.97 0.71 2.63% 0.00% 22-Nov-2010 1.14 3.11 38.64 0.73 2.59% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  5 people like this.
 
SS13 Yes today last day. X-dividend RM0.08 Mon 27July.
24/07/2020 9:23 AM
T800Terminator Q at 2.50 t average. Wish can get.
24/07/2020 12:41 PM
pingoboy Thank you. I will hold and Q again at lower price to bring down my average cost.

@Iamnotasifu Just hold, same tactic from sharks and IBs again, make it limit up then everyone coming to buy, on the second day morning sure a lot of sellings due to profit taking and it form a V shaped recovery in afternoon. Just hold it la, no worries lol
24/07/2020 2:35 PM
kd88 A vaccine in development by the British-Swedish company AstraZeneca and the University of Oxford is based on a chimpanzee adenovirus called ChAdOx1. Their Phase I/II trial, reported on July 20 in the journal Lancet, found that the vaccine was safe, causing no severe side effects. It raised antibodies against the coronavirus as well as other immune defenses. The vaccine is now in a Phase II/III trial in England, as well as Phase III trials in Brazil and South Africa. The project may deliver emergency vaccines by October. AstraZeneca has said their total manufacturing capacity for the vaccine, if approved, stands at two billion doses.
25/07/2020 11:49 AM
kd88 The German company BioNTech has entered into collaborations with Pfizer, based in New York, and the Chinese drug maker Fosun Pharma to develop their mRNA vaccine. In July, they posted preliminary results from their Phase I/II trials in the United States and Germany. They found that the volunteers produced antibodies against SARS-CoV-2, as well as immune cells called T cells that respond to the virus. Some volunteers experienced moderate side effects such as sleep disturbances and sore arms.

The company expects to start Phase III trials by the end of July. On July 22, the Trump administration awarded a $1.9 billion contract for 100 million doses to be delivered by December and the option to acquire 500 million more doses. If approved, Pfizer said they expect to manufacture over 1.3 billion doses of their vaccine by the end of 2021.
25/07/2020 11:50 AM
Toplove888 Sleep counter waited for so long finally sold off earn less than my penny... laggard healthcare
27/07/2020 6:38 AM
T800Terminator Rise with top two health care stock.....this week 3.00?
27/07/2020 11:51 AM
Danu98 This Taiwanese counter lame one
30/07/2020 5:01 PM
T800Terminator Next week Q at 2.35 to average again.
30/07/2020 6:57 PM
chshzhd good move ..
03/08/2020 4:03 PM
chshzhd bravo
05/08/2020 12:25 PM
SS13 Moving up
05/08/2020 2:48 PM
SS13 Can break RM2.80 today?
05/08/2020 3:56 PM
SS13 Strong buying today to close at RM2.80
05/08/2020 6:09 PM
charlietan89 Finally, YSPSAH, warmed Up and ready to go fly like other Pharma stocks!
06/08/2020 1:00 AM
SS13 Will RM3 be in sight today. Watch this space.
06/08/2020 8:51 AM
SS13 Tank empty at RM2.90
06/08/2020 11:23 AM
chshzhd even 3.50 pe only 20 with 3% dy .. what a gem of pharmacy .
07/08/2020 12:48 PM
pinetree88 Got in today YSP at 2.67. Was looking at duopharma last wk but missed out at 2.7+. But saw YSP valuations seem cheaper than the duo, kontra and the rest.
10/08/2020 4:16 PM
chshzhd u r right @pinetree88
10/08/2020 9:22 PM
chshzhd buy .. in .. today ..
11/08/2020 4:25 PM
Kalaihselvan Krishnan Went in at 2.51
12/08/2020 5:52 PM
Fly888888 pharma , dpharma sudah terbang ... amboi , ysp bila kau terbang ye ... ?
13/08/2020 3:20 PM
chshzhd keep .. buying .. :)
14/08/2020 5:47 PM
hahasong 现在很多人买PWORTH股票

很便宜,0.04

值得购买!

Many people now buy PWORTH stock

Very cheap, 0.04

worth buying!
18/08/2020 9:39 AM
Fly888888 那里便宜哦????
18/08/2020 10:51 AM
chshzhd yspsah 才便宜:)
19/08/2020 5:05 PM
GorengHealthcare push push push!
24/08/2020 10:55 AM
GorengHealthcare Still very cheap compared to Pharm,DP,Kotra and AHealth...
25/08/2020 9:16 PM
chshzhd good qr .. buy ..
26/08/2020 8:55 AM
ShareNews wah...this company rich of CASH of 104mils...almost 74sen per share with low borrowings. BUY BUY BUY
26/08/2020 10:18 AM
Keyman188 As per 2019 annual report

Cash & Cash equivalent : RM 90,083,000

Less Loan & Borrowings : RM 28,831,000 + RM 9,915,000

So net cash now : RM 51,337,000


** Don't simply tembak
26/08/2020 10:22 AM
ShareNews you just c the latest QR lo...
26/08/2020 10:26 AM
Klse0314 good counter to invest no matter long term or short term, long term invest to earn dividend compared bank interest which lower now. short term invest if vaccine is available, investor favor hearth care counter
26/08/2020 11:10 AM
chshzhd no problem .. just keep ..
26/08/2020 11:46 AM
Benlee88888 Long term shares. No problem
Slowly slowly up, I like it.
26/08/2020 1:54 PM
chshzhd cheapest pharma counter with 3% div (highest among others)
27/08/2020 12:31 AM
mayongzheng https://youtu.be/eIgQAOLapj8
01/09/2020 8:54 PM
cpng 永信藥品聚焦重症感染藥物
今年營運續增6%

永信藥品聚焦發展重症感染藥物,深化自原料藥至製劑垂直整合技術能力;今年因應疫情衝擊拉高原料庫存,原料成本均上揚,全年業績仍可望拚6%成長,維持穩定成長趨勢。

永信藥品今年由於疫情關係,各國對於抗疫物資的出口已相對保守,原物料供應鏈不若以往寬鬆,為確保生產線供貨穩定,避免來自中國大陸的料缺貨,去年底已陸續將原料存量拉高35%,目前外銷市場及內銷市場約2比8,每年成長6%的目標不變,各個品項成長動能均衡。

永信為全球少數擁有生物醱酵、化學合成技術以及藥品處方快篩技術綜合型藥廠。

近年來,由於抗生素的廣泛使用而產生抗藥性細菌,對病患健康產生重大威脅。

過去由於注射型抗黴菌藥物藥價昂貴、與臨床使用上的安全性問題,限制了病患的用藥時機與療程。

永信針對感染性疾病,持續深耕發展抗感染藥物,除了早期開發的廣效型抗生素藥物、中期發展預防性黴菌感染與抗病毒藥物,近期更朝向需求日增的重症感染領域,目前已經成功開發3項產品。

其中與台微體攜手合作,掌握特殊奈米化微脂體劑型的關鍵製程,已成功量產Amphotericin B (微脂體製劑),目前正配合進行歐、美、中等大型市場的查登作業。
03/09/2020 10:02 AM
cpng Taiwanese new special medicine Silmitasertib (CX-4945) cured covid 19 in 5 days time.

http://www.senhwabiosciences.com/tw/new?cls=1491881153&guid=1599104946
03/09/2020 2:15 PM
Deskent may I know dividend 8sen when will announce?
11/09/2020 10:44 AM
chesslim Dividen 8sen already bank in to a/c at Aug. 25. 2020
11/09/2020 5:26 PM
hahasong United States vaccine failed!

The glove unit ESCERAM 0100 is about to fly!
17/09/2020 9:34 AM
50Cents Post removed. Why?
08/10/2020 1:23 AM
Flymetothemoon Post removed. Why?
14/10/2020 7:22 PM
Investsucess Trader Very good and profitable stock,resilent, one of the best.
25/10/2020 9:31 AM
chshzhd good fundamental
30/10/2020 8:47 AM
NPRA1985 Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December

“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”

https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
07/11/2020 2:29 AM
NPRA1985 China National Pharmaceutical Group Corp (SINOPHARM), a Chinese state-owned enterprise, announced on Wednesday that data from late-stage clinical trials for its Covid-19 vaccine are «BETTER THAN EXPECTED», Reuters reported.

In Morocco, Dr. Abdelhakim Yahyane, a member of the National Scientific Advisory Committee on Vaccination, told Yabiladi earier this week that vaccine trials in the country «have REACHED THE FINAL PHASE».

We are impatiently awaiting the end of this process, which could probably happen BY NEXT WEEK

https://en.yabiladi.com/articles/details/101544/conducted-morocco-among-others-sinopharm-s.html
13/11/2020 9:53 PM
NPRA1985 Post removed. Why?
23/11/2020 1:59 PM